RUXOLITINIB CIPLA 20 mg
The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.
- Active substance
- Ruxolitinib
- Strength
- 20 mg
- Form
- comprimido
- ATC code
- L01EJ01
- Registered in
- Spain · Cipla Europe N.V.
- Prescription
- Prescription only
- Nº Registro
- 91526
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30
Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.
Listed in other countries
United States 1 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| Jakafi | 20 mg · Tablet | Prescription only | Incyte Corporation | 50881-020 |
Source: NDC Directory (US Food and Drug Administration) · 2026-09-13 · Source: US Food and Drug Administration, NDC Directory.
Bulgaria 2 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| RujaviРуджави | 20 mg · tablets | Prescription only | Нобел Фарма ЕООД | 20260212 |
| Ruxolitinib DevatisРуксолитиниб Devatis | 20 mg · tablets | Prescription only | Devatis GmbH | 20260284 |
Source: Bulgarian Drug Agency register (Изпълнителна агенция по лекарствата (BDA)) · 2026-08-01
Canada 1 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| JAKAVI | 20 mg · tablet | Prescription only | Novartis Pharmaceuticals Canada Inc | 02388022 |
Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.
Netherlands 8 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| Jakavi 20 mg | 20 mg · tablet | Prescription only | Novartis Europharm Limited | EU/1/12/773 |
| Ruxolitinib Accord 20 mg | 20 mg · tablet | Prescription only | Accord Healthcare B.V. | 134220 |
| Ruxolitinib Advanz Pharma 20 mg tabletten | 20 mg · tablet | Prescription only | Advanz Pharma Limited | 134216 |
| Ruxolitinib Devatis 20 mg | 20 mg · tablet | Prescription only | Devatis GmbH | 134898 |
| Ruxolitinib Medichem 20 mg tabletten | 20 mg · tablet | Prescription only | Medichem S.A. | 134212 |
| Ruxolitinib MSN 20 mg tabletten | 20 mg · tablet | Prescription only | Vivanta Generics s.r.o. | 133973 |
2 more names not shown. Source: Geneesmiddeleninformatiebank (College ter Beoordeling van Geneesmiddelen (CBG-MEB)) · 2026-09-30 · Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site.
Same active substance, but no match for this strength and form
- European Union: 3 products · Every strength and form
- Switzerland: 13 products · Every strength and form